Explore the world of textured and layered abstract art with this step-by-step tutorial showcasing three innovative projects. Learn how to use modeling paste, acrylic paints, and stencils to create ...

Across industries, organizations are transforming how they deliver value. From engineering to IT services to internal PMOs, leaders are rethinking their operating models to become more service-centric ...

How should a state IT department decide which modernization projects get priority? As states across the country continue to focus on modernization, this can be a pressing question. But one state — ...

FDA accepted Replimune’s resubmitted Biologics License Application for RP1 combined with Bristol Myers Squibb’s Opdivo to treat advanced melanoma The agency set April 10, 2026 as the decision deadline ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

Beat boredom with over 40 fun and easy crochet projects! Each comes with free step-by-step tutorials, perfect for beginners or anyone looking for creative DIY ideas. #CrochetProjects #DIYCrochet ...

J S Link America Inc. plans to invest approximately $223 million to establish a new rare earth permanent magnet manufacturing facility in Columbus, Georgia. The new facility will create more than 520 ...

OpenAI has announced that it's making its Projects feature available to free users of ChatGPT. Projects let you organize chats with the company's AI assistant around a specific subject, and were ...

On July 22, 2025, the U.S. Food and Drug Administration issued a Complete Response Letter for RP1, delaying potential commercialization and revenue. Research and development expenses increased 34.6% ...

Replimune (NASDAQ:REPL) climbed more than 100% on Wednesday as Cantor Fitzgerald upgraded the cancer drug developer, citing a potential reversal of an FDA decision that rejected its lead drug ...

SAN FRANCISCO, July 28, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit, styled Jboor v. Replimune Group, Inc., et al., No. 1:25-cv-12085 (D. Mass.), has been filed and seeks to represent ...